ZNF221
gene geneOn this page
Summary
ZNF221 (zinc finger protein 221, HGNC:13014) is a protein-coding gene on chromosome 19q13.31, encoding Zinc finger protein 221 (Q9UK13). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 7638 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 102 total
- MANE Select transcript:
NM_001297588
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13014 |
| Approved symbol | ZNF221 |
| Name | zinc finger protein 221 |
| Location | 19q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000159905 |
| Ensembl biotype | protein_coding |
| Entrez | 7638 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 6 protein_coding
ENST00000251269, ENST00000587682, ENST00000591168, ENST00000592350, ENST00000622072, ENST00000886290
RefSeq mRNA: 3 — MANE Select: NM_001297588
NM_001297588, NM_001297589, NM_013359
CCDS: CCDS12633
Canonical transcript exons
ENST00000587682 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000847471 | 43962725 | 43962807 |
| ENSE00002532872 | 43965233 | 43965325 |
| ENSE00002707868 | 43964950 | 43965076 |
| ENSE00002799284 | 43965804 | 43967709 |
| ENSE00002878009 | 43951228 | 43951400 |
Expression profiles
Bgee: expression breadth ubiquitous, 163 present calls, max score 82.03.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.3283 / max 172.2434, expressed in 1170 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 176237 | 3.3283 | 1170 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.03 | gold quality |
| buccal mucosa cell | CL:0002336 | 80.44 | silver quality |
| calcaneal tendon | UBERON:0003701 | 79.58 | gold quality |
| tendon | UBERON:0000043 | 76.94 | gold quality |
| stromal cell of endometrium | CL:0002255 | 75.22 | gold quality |
| cortical plate | UBERON:0005343 | 74.53 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 73.37 | gold quality |
| hair follicle | UBERON:0002073 | 72.81 | gold quality |
| adrenal tissue | UBERON:0018303 | 71.26 | gold quality |
| corpus callosum | UBERON:0002336 | 71.23 | gold quality |
| ventricular zone | UBERON:0003053 | 71.08 | gold quality |
| medial globus pallidus | UBERON:0002477 | 70.39 | gold quality |
| sural nerve | UBERON:0015488 | 70.03 | gold quality |
| ganglionic eminence | UBERON:0004023 | 68.68 | gold quality |
| globus pallidus | UBERON:0001875 | 67.99 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 66.88 | gold quality |
| islet of Langerhans | UBERON:0000006 | 66.73 | gold quality |
| cerebellar cortex | UBERON:0002129 | 64.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 64.25 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 64.23 | gold quality |
| cerebellum | UBERON:0002037 | 63.97 | gold quality |
| parotid gland | UBERON:0001831 | 63.90 | gold quality |
| colonic epithelium | UBERON:0000397 | 63.47 | silver quality |
| adrenal gland | UBERON:0002369 | 63.32 | gold quality |
| bone marrow cell | CL:0002092 | 62.82 | silver quality |
| left adrenal gland | UBERON:0001234 | 62.63 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 62.15 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 61.85 | gold quality |
| cerebellar vermis | UBERON:0004720 | 61.58 | gold quality |
| right adrenal gland | UBERON:0001233 | 61.50 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7249 | no | 29.99 |
| E-ANND-3 | no | 3.86 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
20 targeting ZNF221, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-1827 | 99.63 | 68.57 | 3265 |
| HSA-MIR-1260A | 99.61 | 66.67 | 1098 |
| HSA-MIR-1260B | 99.61 | 66.67 | 1098 |
| HSA-MIR-6734-3P | 99.15 | 66.27 | 1627 |
| HSA-MIR-7160-5P | 99.11 | 67.17 | 2207 |
| HSA-MIR-129-1-3P | 98.86 | 68.41 | 779 |
| HSA-MIR-129-2-3P | 98.86 | 68.41 | 779 |
| HSA-MIR-6728-3P | 98.63 | 67.63 | 1534 |
| HSA-MIR-7114-5P | 98.51 | 67.87 | 1349 |
| HSA-MIR-5008-5P | 98.42 | 65.87 | 1019 |
| HSA-MIR-1245B-3P | 98.01 | 68.91 | 1387 |
| HSA-MIR-7847-3P | 96.63 | 64.58 | 952 |
| HSA-MIR-4790-3P | 96.63 | 67.08 | 806 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)
Protein
Protein identifiers
Zinc finger protein 221 — Q9UK13 (reviewed: Q9UK13)
All UniProt accessions (2): Q9UK13, A0A5H1ZRS7
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (3): NP_001284517, NP_001284518, NP_037491 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352
UniProt features (24 total): zinc finger region 15, sequence variant 6, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9UK13-F1 | 70.39 | 0.08 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 61 (showing top):
GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, NOTCH_DN.V1_DN, JAK2_DN.V1_DN, GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CHAMP1_TARGET_GENES, DIDO1_TARGET_GENES, GLI4_TARGET_GENES, HES2_TARGET_GENES, RYBP_TARGET_GENES, ZNF197_TARGET_GENES, ZNF30_TARGET_GENES
GO Biological Process (3): regulation of DNA-templated transcription (GO:0006355), negative regulation of transcription by RNA polymerase II (GO:0000122), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (8): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872), sequence-specific double-stranded DNA binding (GO:1990837)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 3 |
| regulation of transcription by RNA polymerase II | 2 |
| transcription by RNA polymerase II | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| negative regulation of DNA-templated transcription | 1 |
| regulation of DNA-templated transcription | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| negative regulation of transcription by RNA polymerase II | 1 |
| DNA-binding transcription factor activity, RNA polymerase II-specific | 1 |
| DNA-binding transcription repressor activity | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
218 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF221 | OR10J1 | P30954 | 507 |
| ZNF221 | OR11A1 | Q9GZK7 | 507 |
| ZNF221 | ZSWIM1 | Q9BR11 | 478 |
| ZNF221 | PRDM10 | Q9NQV6 | 431 |
| ZNF221 | CARD19 | Q96LW7 | 418 |
| ZNF221 | C19orf53 | Q9UNZ5 | 407 |
| ZNF221 | GPATCH4 | Q5T3I0 | 404 |
| ZNF221 | SLC27A5 | Q9Y2P5 | 387 |
| ZNF221 | CTCFL | Q8NI51 | 385 |
| ZNF221 | NECAB1 | Q8N987 | 370 |
| ZNF221 | DUS2 | Q9NX74 | 370 |
| ZNF221 | CEMP1 | Q6PRD7 | 348 |
| ZNF221 | LHFPL6 | Q9Y693 | 322 |
| ZNF221 | CRYBA2 | P53672 | 312 |
| ZNF221 | KIAA1217 | Q5T5P2 | 310 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGEA8 | ZNF221 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MDFI | ZNF221 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-6 | ZNF221 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF221 | ZNF284 | psi-mi:“MI:0914”(association) | 0.530 |
| ZNF221 | CDK11B | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF221 | MAGEA8 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF221 | MDFI | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF221 | KRTAP10-6 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): ZNF225 (Affinity Capture-MS), CDK11B (Affinity Capture-MS), ZNF284 (Affinity Capture-MS), ZNF221 (Affinity Capture-RNA), ZNF221 (Affinity Capture-MS), ZNF221 (Two-hybrid), ZNF221 (Two-hybrid), KRTAP10-6 (Two-hybrid), ZNF221 (Affinity Capture-RNA), ZNF225 (Affinity Capture-MS), ZNF284 (Affinity Capture-MS), ZNF221 (Affinity Capture-MS)
ESM2 similar proteins: A0JNB1, A1YF12, A1YG88, A2T759, A6QLU5, B2RUI1, D3ZVT0, O14709, O43296, O75123, P10072, P15621, P17020, P17097, P51814, P85977, Q08ER8, Q0VGE8, Q14590, Q32KN0, Q3KQV3, Q4V8A8, Q5CZA5, Q5RBX0, Q5RCD9, Q5VIY5, Q61116, Q61967, Q6GQR8, Q6P9A3, Q6ZMS4, Q7TSH9, Q7TSI0, Q7Z3I7, Q86UD4, Q86WZ6, Q8BFS8, Q8IZ26, Q8N9F8, Q8TAF7
Diamond homologs: A0A1W2PQL4, A0JNB1, A0JPL0, A6NK53, A6QLU5, A6QPT6, A7MBI1, A8MT65, A8MUV8, A8MWA4, B2RXC5, B4DU55, B4DX44, E9PYI1, O14628, O75346, P0CH99, P0CI00, P17014, P17030, P17032, P17098, P51786, P85977, Q02386, Q06730, Q06732, Q0VAW7, Q12901, Q13360, Q14586, Q14588, Q14590, Q16587, Q2M3X9, Q2VY69, Q32M78, Q3ZCX4, Q49AA0, Q4R6J4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
102 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 99 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
590 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:43951375:A:T | donor_gain | 1.0000 |
| 19:43951379:G:GT | donor_gain | 1.0000 |
| 19:43951392:A:T | donor_gain | 1.0000 |
| 19:43962703:T:TA | acceptor_gain | 1.0000 |
| 19:43962712:T:TA | acceptor_gain | 1.0000 |
| 19:43962713:G:A | acceptor_gain | 1.0000 |
| 19:43962808:G:GG | donor_gain | 1.0000 |
| 19:43964948:A:G | acceptor_loss | 1.0000 |
| 19:43964949:G:GC | acceptor_loss | 1.0000 |
| 19:43965073:GTAG:G | donor_gain | 1.0000 |
| 19:43965231:A:AG | acceptor_gain | 1.0000 |
| 19:43965231:AG:A | acceptor_gain | 1.0000 |
| 19:43965232:G:GG | acceptor_gain | 1.0000 |
| 19:43965232:GG:G | acceptor_gain | 1.0000 |
| 19:43965323:CAGGT:C | donor_loss | 1.0000 |
| 19:43965326:G:GA | donor_loss | 1.0000 |
| 19:43965326:G:GG | donor_gain | 1.0000 |
| 19:43965327:T:G | donor_loss | 1.0000 |
| 19:43965800:TTAG:T | acceptor_loss | 1.0000 |
| 19:43965802:A:AG | acceptor_gain | 1.0000 |
| 19:43965802:A:T | acceptor_loss | 1.0000 |
| 19:43965802:AGGAG:A | acceptor_gain | 1.0000 |
| 19:43965803:G:GG | acceptor_gain | 1.0000 |
| 19:43965803:G:GT | acceptor_loss | 1.0000 |
| 19:43965803:GGA:G | acceptor_gain | 1.0000 |
| 19:43965803:GGAGG:G | acceptor_gain | 1.0000 |
| 19:43951409:GG:G | donor_gain | 0.9900 |
| 19:43951410:GG:G | donor_gain | 0.9900 |
| 19:43962716:A:AG | acceptor_gain | 0.9900 |
| 19:43962724:GGC:G | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000167051 (19:43973625 G>A), RS1000280509 (19:43981695 C>T), RS1000377306 (19:43967411 A>G), RS1000509019 (19:43956823 CTG>C), RS1000530153 (19:43968547 C>G,T), RS1000533808 (19:43961224 G>T), RS1000699013 (19:43975682 C>G), RS1000708335 (19:43975996 A>G), RS1000964383 (19:43968865 C>A), RS1001313475 (19:43963939 A>G,T), RS1001536899 (19:43955307 GACAA>G), RS1001581088 (19:43951299 C>G,T), RS1001769144 (19:43957864 A>G), RS1002063079 (19:43975627 C>A), RS1002133240 (19:43963288 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010146_16 | Serum immune biomarker levels | 3.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004869 | YKL40 measurement |
| EFO:0004872 | inflammatory biomarker measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | decreases reaction, increases expression, increases abundance | 3 |
| Vehicle Emissions | decreases reaction, increases expression, increases abundance | 2 |
| TAK-243 | increases sumoylation | 1 |
| butyraldehyde | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases reaction, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | affects expression | 1 |
| Urethane | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW21 | HEK293 eGFP-ZNF221 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.